LCN2 and TWEAK synergistically interact with Fn14, leading to epidermal proliferation and inflammation in psoriasis through the MAPK signaling pathway; however, these effects can be reversed by LCN2 knockout. The gene discussed is TNFSF12; the disease is psoriasis.